Different characteristics of quality of life in celiac disease patients

  • Authors: Moiseenko E.E.1, Osipenko M.F.1, Ageeva T.A.1, Krotov S.A.1, Burbik NN1, Moiseenko EE2, Osipenko MF2, Ageeva TA2, Krotov SA3, Burbik NN3
  • Affiliations:
    1. State Medical University, Novosibirsk
    2. Vektor-Best Corporation, Novosibirsk
  • Issue: Vol 83, No 2 (2011)
  • Pages: 25-28
  • Section: Articles
  • URL: https://ter-arkhiv.ru/0040-3660/article/view/30796
  • Cite item


Aim. To study quality of life (QoL) in patients with celiac disease (CD) in the course of treatment with aglutenic diet (AD).
Material and methods. Modern algorithm of glutenic enteropathy diagnosis (enzyme immunoassay, histological examination of the biopsy of distal duodenum mucosa) was used in 650 patients with different gastrointestinal symptoms. QoL was assessed in the course of AD treatment of CD with application of universal standard questionnaire MOS SF-36.
Results. CD was diagnosed in 56 (8.6%) patients. Classic CD was diagnosed in 44 (78.6%) patients, atypical CD - in 12 (21.4%). Significant lowering of QoL characteristic "psychological health" was observed in CD patients under 30 and over 50 and "physical health" in 30-50-year-old CD patients. Women had low points on "mental health" scale. After 3 AD months QoL worsened by all the scales, but after 12 months QoL significantly improved.
Conclusion. QoL in patients with classic CD is associated with gender and age. First, AD deteriorates QoL, but 1-year diet therapy improves QoL.

About the authors

Elena Evgen'evna Moiseenko

Marina Fedorovna Osipenko

Email: ngma@ngs.ru

Tat'yana Avgustovna Ageeva

Sergey Aleksandrovich Krotov

Email: krotov@vector-best.ru

N N Burbik

Email: burbik@vector-best.ru

E E Moiseenko

State Medical University, Novosibirsk

State Medical University, Novosibirsk

M F Osipenko

State Medical University, Novosibirsk

State Medical University, Novosibirsk

T A Ageeva

State Medical University, Novosibirsk

State Medical University, Novosibirsk

S A Krotov

Vektor-Best Corporation, Novosibirsk

Vektor-Best Corporation, Novosibirsk

N N Burbik

Vektor-Best Corporation, Novosibirsk

Vektor-Best Corporation, Novosibirsk


  1. Duby C., Rostom A., Sy R. et al. The prevalence of celiac disease in average-risk and at-risk Western European: A systematic review. Gastroenterology 2005; 128: 4.
  2. Hoffenberg E. J., Mackenzie T., Barriga K. G. et al. A prospective study of the incidence of childhood celiac disease. Pediatrics 2003; 143: 308-314.
  3. Cook H. B., Burt M. G. Adult celiac disease: prevalence and clinical significance. J. Gastroenterol. Hepatol. 2000; 15 (9): 1032-1036.
  4. Парфенов А. И. Целиакия в XXI веке. Тер. арх. 2003; 2: 5- 9.
  5. Репин А. А., Богдарин Ю. А., Саранцев Б. В. Распространенность целиакии в Нижегородской области среди пациентов группы риска. Тер. арх. 2008; 2: 38-44.
  6. Новак А. А. Концепция исследования качества жизни в медицине. Рус. мед. журн. 2006; 2: 81-85.
  7. Эммануэль В. Л., Вохмянина Н. В., Ревнова М. О. Лабораторная диагностика целиакии. Иммунология 2000; 5: 37- 40.
  8. McGowan K. E., Lyon M. E., Butzner J. D. Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin. Chem. 2008; 54 (7): 1203- 1209.
  9. Marsh M. N. Mucosal pathology in gluten sensitivity. Celiac disease. Oxford; 1992. 136-191.
  10. Парфенов А. А. Целиакия. Эволюция представлений о распространенности, клинических представлениях и значимости этиотропной терапии. М.: Анахарсис; 2007.
  11. Орешко Л. С. Психологические особенности больных целиакией. Психол. больного 2005; 3: 72-74.



Abstract - 44



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies